PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
28
about 4.2 years
18+
2 sites in FL
What this study is about
This trial is testing a new type of radiation therapy called PRDR to see if it can help people with recurrent brain cancers. The goal is to determine the safety and effectiveness of this treatment approach in patients who have previously been treated for high-grade gliomas.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive PRDR
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Progression-free survival (PFS)
Secondary: Assessment of symptoms using the MD Anderson Symptom Inventory for Brain Tumors (MDASI-BT), Overall survival (OS), Quality of life (QOL) assessed by the EuroQOL 5-dimension, 5-level (EQ-5D-5L), Treatment-related adverse events (AEs) assessed by Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v5.0)